They showed a higher risk of colon cancer for those with IGF‐1 levels in the third (137–174 ng/mL) and fourth quartiles (IGF‐1 > 174 ng/mL) as compared to the controls (OR of 2.2 and 1.8, respectively). This evidence concerns the gene IGF1 and colonic neoplasm.